Episode Details

Back to Episodes
Gene Therapy and Longevity: How Far Would You Travel to Live Longer?

Gene Therapy and Longevity: How Far Would You Travel to Live Longer?

Published 9 months, 2 weeks ago
Description

"Aging is the greatest medical unmet need and the biggest killer on the planet."

In this episode, I interview Elizabeth Parrish, the CEO of BioViva, known as Patient Zero. Elizabeth was the first person to have gene replacement therapy and traveled to South America to do so. Years later, she looks and feels like thirty at age 51.

Sharing her groundbreaking journey into gene therapy and its implications for aging, Parrish discusses the controversial nature of this field, the science behind gene therapy, and the potential for longevity travel outside the USA.

This podcast is my prelude to the RAADFEST Conference series on healthy aging and travel. After her treatments, Liz started longevity travel centers in various locations. Discover them in our upcoming series on "Longevity Travel." 

Resources:

Elizabeth Parrish
https://bioviva-science.com

Bioviva
https://bioviva-science.com

RadFest
https://radfest.com

National Institute on Aging
https://nia.nih.gov

PNAS
https://pnas.org

SUBSCRIBE FREE Weekly Travel Tuesday Newsletter

https://ageless-traveler-s-travel-tuesday.kit.com/b368fe9fec 

JOIN OUR PRIVATE FACEBOOK SALON AT XXXXX 

Check out our Website: The Ageless Traveler https://agelesstraveler.com 

Leave a voicemail or text- https://fanlist.com/agelesstraveler/inbox/ask-your-travel-questions-here 

Get our discounts when you book hotels, rental cars, and tour guides, use these links created for you by The Ageless Traveler

Cruises It

https://theagelesstraveler.membercruises.com/home-page

Expedia

https://expedia.stay22.com/agelesstraveler/vhJWi3-pJc

Booking.com

https://booking.stay22.com/agelesstraveler/ilhSeKdutq

Hotels.com

https://hotelscom.stay22.com/agelesstraveler/4wOCouV7MN



Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us